Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Smallridge

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumorsChristopher B Umbricht, George T Conrad, Douglas P Clark, et al.
Thyroid : Official Journal of the American Thyroid Association|September 9, 2020
Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid GuidelinesAnna M Sawka, Erik K Alexander, Antonio C Bianco, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2008
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentificationRebecca E Schweppe, Joshua P Klopper, Christopher Korch, et al.
Cancer Research|December 10, 2014
miR30a inhibits LOX expression and anaplastic thyroid cancer progressionMyriem Boufraqech, Naris Nilubol, Lisa Zhang, et al.
JAMA Network Open|September 30, 2020
Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin LevelsJuan P Brito, Joseph S Ross, Lindsey Sangaralingham, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2020
Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic TherapyNicole M Iñiguez-Ariza, Sina Jasim, Mabel M Ryder, et al.
Endocrine|June 5, 2021
Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine useJuan P Brito, Joseph S Ross, Yihong Deng, et al.
Science Translational Medicine|January 4, 2013
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancerCrescent R Isham, Ayoko R Bossou, Vivian Negron, et al.
Oncotarget|May 6, 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancerLisa Zhang, Yaqin Zhang, Amit Mehta, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor XenograftsLaura A Marlow, Stephen D Rohl, James L Miller, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumorsChristopher B Umbricht, George T Conrad, Douglas P Clark, et al.
Thyroid : Official Journal of the American Thyroid Association|September 9, 2020
Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid GuidelinesAnna M Sawka, Erik K Alexander, Antonio C Bianco, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2008
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentificationRebecca E Schweppe, Joshua P Klopper, Christopher Korch, et al.
Cancer Research|December 10, 2014
miR30a inhibits LOX expression and anaplastic thyroid cancer progressionMyriem Boufraqech, Naris Nilubol, Lisa Zhang, et al.
JAMA Network Open|September 30, 2020
Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin LevelsJuan P Brito, Joseph S Ross, Lindsey Sangaralingham, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2020
Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic TherapyNicole M Iñiguez-Ariza, Sina Jasim, Mabel M Ryder, et al.
Endocrine|June 5, 2021
Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine useJuan P Brito, Joseph S Ross, Yihong Deng, et al.
Science Translational Medicine|January 4, 2013
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancerCrescent R Isham, Ayoko R Bossou, Vivian Negron, et al.
Oncotarget|May 6, 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancerLisa Zhang, Yaqin Zhang, Amit Mehta, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor XenograftsLaura A Marlow, Stephen D Rohl, James L Miller, et al.
Pageof 7